文献速递乳房整形与再造

乳房切除术后辅助放疗用于直接植入与两阶段植入物乳房重建:一项Meta分析

Post-mastectomy adjuvant radiotherapy for direct-to-implant and two-stage implant-based breast reconstruction: A meta-analysis.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2022-06-22

该Meta分析纳入22项研究共6964例患者,评估乳房切除术后放疗(PMRT)对直接植入(DTI)与两阶段(TEI)植入物乳房重建结局的影响。PMRT增加DTI患者包膜挛缩风险,并导致TEI患者其他并发症;PMRT组与非放疗组包膜挛缩率在IBR为17.01% vs 3.30%(p<0.01),DTI为15.49% vs 5.70%(p<0.01)。

要点

  • PMRT增加DTI患者包膜挛缩风险,并导致TEI患者其他并发症。
  • PMRT组与非放疗组包膜挛缩率:IBR 17.01% vs 3.30%(p<0.01),DTI 15.49% vs 5.70%(p<0.01)。
  • 永久植入物与组织扩张器引起的包膜挛缩及其他并发症率相似。

核心结论

  • PMRT与IBR(包括DTI术式)更高的并发症和包膜挛缩风险相关。
  • 该负面影响可能与放疗时乳房内容物类型无关。

研究设计与样本

  • Meta分析,检索PubMed/Embase/The Cochrane Library数据库(1995-2021年),经排除标准筛选研究。
  • 共纳入22项研究、6964例患者;病例分为PMRT组与非放疗组,PMRT组再分为永久植入物组与组织扩张器组。
  • 结局为包膜挛缩及其他并发症。

主要发现

  • PMRT组与非放疗组包膜挛缩平均率:IBR为17.01% vs 3.30%(p<0.01),DTI为15.49% vs 5.70%(p<0.01)。
  • PMRT组与非放疗组其他并发症平均率:IBR为22.59% vs 11.29%(p<0.01),DTI为31.88% vs 27.87%(p=0.35),TEI为22.11% vs 9.90%(p<0.01)。
  • 永久植入物与组织扩张器引起的包膜挛缩及其他并发症率相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In recent years, immediate replacement with a prosthesis (direct-to-implant, DTI) is gaining more popularity than two-staged methods (tissue expander followed by an implant, TEI). The safety of immediate implant-based breast reconstruction (IBR) is debatable when postmastectomy radiotherapy (PMRT) is indicated. This meta-analysis aims to evaluate the outcomes of DTI and TEI procedures followed by PMRT. METHODS: Studies searched in the PubMed/Embase/The Cochrane Library databases (1995-2021) were filtered by exclusion criteria. Cases were divided into PMRT and non-irradiated groups, PMRT with a permanent implant or tissue expander. The outcomes were capsular contracture and other complications. RESULTS: A total of 22 studies with 6964 patients were included. PMRT increased the risk of capsular contracture in DTI patients and caused other complications in TEI patients. In PMRT and non-irradiated groups, the mean rates of capsular contracture were 17.01% versus 3.30% (p < 0.01) in IBR and 15.49% versus 5.70% (p < 0.01) in DTI. The mean rates of other complications were 22.59% versus 11.29% (p < 0.01) in IBR, 31.88% versus 27.87% (p = 0.35) in DTI, and 22.11% versus 9.90% (p < 0.01) in TEI. Implants and tissue expanders caused a similar rate of capsular contracture and other complications. CONCLUSION: PMRT is related to a higher risk of complication and capsular contracture in IBR, including DTI procedure. This negative effect may not be related to the type of breast contents during radiotherapy.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Du F, Liu R, Zhang H, et al. Post-mastectomy adjuvant radiotherapy for direct-to-implant and two-stage implant-based breast reconstruction: A meta-analysis. J Plast Reconstr Aesthet Surg. 2022. PMID: 35961927. doi:10.1016/j.bjps.2022.06.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。